Pharma & Healthcare
Global Amiodarone Market Research Report 2025
- Sep 09, 25
- ID: 496511
- Pages: 78
- Figures: 80
- Views: 4
Report Scope
This report aims to provide a comprehensive presentation of the global market for Amiodarone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amiodarone.
The Amiodarone market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Amiodarone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Amiodarone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Sanofi
Sawai Pharmaceutical
Wyeth Pharmaceuticals(Pfizer)
Mylan Pharmaceuticals
Arrow Pharma Pty Ltd
Roemmers
Cipla Pharmaceutical
Shanghai Pharmaceuticals
North China Pharmaceutical Company
Harbin Pharmaceutical Group
Segment by Type
Tablet Amiodarone
Capsule Amiodarone
Injection Amiodarone
Segment by Application
Cardiac Arrest
Ventricular Tachycardia
Atrial Fibrillation
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Amiodarone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Amiodarone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
This report aims to provide a comprehensive presentation of the global market for Amiodarone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amiodarone.
The Amiodarone market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Amiodarone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Amiodarone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Sanofi
Sawai Pharmaceutical
Wyeth Pharmaceuticals(Pfizer)
Mylan Pharmaceuticals
Arrow Pharma Pty Ltd
Roemmers
Cipla Pharmaceutical
Shanghai Pharmaceuticals
North China Pharmaceutical Company
Harbin Pharmaceutical Group
Segment by Type
Tablet Amiodarone
Capsule Amiodarone
Injection Amiodarone
Segment by Application
Cardiac Arrest
Ventricular Tachycardia
Atrial Fibrillation
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Amiodarone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Amiodarone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Amiodarone Market Overview
1.1 Product Definition
1.2 Amiodarone by Type
1.2.1 Global Amiodarone Market Value Comparison by Type (2024 VS 2031)
1.2.2 Tablet Amiodarone
1.2.3 Capsule Amiodarone
1.2.4 Injection Amiodarone
1.3 Amiodarone by Application
1.3.1 Global Amiodarone Market Value by Application (2024 VS 2031)
1.3.2 Cardiac Arrest
1.3.3 Ventricular Tachycardia
1.3.4 Atrial Fibrillation
1.3.5 Others
1.4 Global Amiodarone Market Size Estimates and Forecasts
1.4.1 Global Amiodarone Revenue 2020-2031
1.4.2 Global Amiodarone Sales 2020-2031
1.4.3 Global Amiodarone Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Amiodarone Market Competition by Manufacturers
2.1 Global Amiodarone Sales Market Share by Manufacturers (2020-2025)
2.2 Global Amiodarone Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Amiodarone Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Amiodarone, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Amiodarone, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Amiodarone, Product Type & Application
2.7 Global Key Manufacturers of Amiodarone, Date of Enter into This Industry
2.8 Global Amiodarone Market Competitive Situation and Trends
2.8.1 Global Amiodarone Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Amiodarone Players Market Share by Revenue
2.8.3 Global Amiodarone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Amiodarone Market Scenario by Region
3.1 Global Amiodarone Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Amiodarone Sales by Region: 2020-2031
3.2.1 Global Amiodarone Sales by Region: 2020-2025
3.2.2 Global Amiodarone Sales by Region: 2026-2031
3.3 Global Amiodarone Revenue by Region: 2020-2031
3.3.1 Global Amiodarone Revenue by Region: 2020-2025
3.3.2 Global Amiodarone Revenue by Region: 2026-2031
3.4 North America Amiodarone Market Facts & Figures by Country
3.4.1 North America Amiodarone Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Amiodarone Sales by Country (2020-2031)
3.4.3 North America Amiodarone Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Amiodarone Market Facts & Figures by Country
3.5.1 Europe Amiodarone Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Amiodarone Sales by Country (2020-2031)
3.5.3 Europe Amiodarone Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Amiodarone Market Facts & Figures by Region
3.6.1 Asia Pacific Amiodarone Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Amiodarone Sales by Region (2020-2031)
3.6.3 Asia Pacific Amiodarone Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Amiodarone Market Facts & Figures by Country
3.7.1 Latin America Amiodarone Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Amiodarone Sales by Country (2020-2031)
3.7.3 Latin America Amiodarone Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Amiodarone Market Facts & Figures by Country
3.8.1 Middle East and Africa Amiodarone Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Amiodarone Sales by Country (2020-2031)
3.8.3 Middle East and Africa Amiodarone Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Amiodarone Sales by Type (2020-2031)
4.1.1 Global Amiodarone Sales by Type (2020-2025)
4.1.2 Global Amiodarone Sales by Type (2026-2031)
4.1.3 Global Amiodarone Sales Market Share by Type (2020-2031)
4.2 Global Amiodarone Revenue by Type (2020-2031)
4.2.1 Global Amiodarone Revenue by Type (2020-2025)
4.2.2 Global Amiodarone Revenue by Type (2026-2031)
4.2.3 Global Amiodarone Revenue Market Share by Type (2020-2031)
4.3 Global Amiodarone Price by Type (2020-2031)
5 Segment by Application
5.1 Global Amiodarone Sales by Application (2020-2031)
5.1.1 Global Amiodarone Sales by Application (2020-2025)
5.1.2 Global Amiodarone Sales by Application (2026-2031)
5.1.3 Global Amiodarone Sales Market Share by Application (2020-2031)
5.2 Global Amiodarone Revenue by Application (2020-2031)
5.2.1 Global Amiodarone Revenue by Application (2020-2025)
5.2.2 Global Amiodarone Revenue by Application (2026-2031)
5.2.3 Global Amiodarone Revenue Market Share by Application (2020-2031)
5.3 Global Amiodarone Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Amiodarone Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Amiodarone Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Sawai Pharmaceutical
6.2.1 Sawai Pharmaceutical Company Information
6.2.2 Sawai Pharmaceutical Description and Business Overview
6.2.3 Sawai Pharmaceutical Amiodarone Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sawai Pharmaceutical Amiodarone Product Portfolio
6.2.5 Sawai Pharmaceutical Recent Developments/Updates
6.3 Wyeth Pharmaceuticals(Pfizer)
6.3.1 Wyeth Pharmaceuticals(Pfizer) Company Information
6.3.2 Wyeth Pharmaceuticals(Pfizer) Description and Business Overview
6.3.3 Wyeth Pharmaceuticals(Pfizer) Amiodarone Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Wyeth Pharmaceuticals(Pfizer) Amiodarone Product Portfolio
6.3.5 Wyeth Pharmaceuticals(Pfizer) Recent Developments/Updates
6.4 Mylan Pharmaceuticals
6.4.1 Mylan Pharmaceuticals Company Information
6.4.2 Mylan Pharmaceuticals Description and Business Overview
6.4.3 Mylan Pharmaceuticals Amiodarone Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Mylan Pharmaceuticals Amiodarone Product Portfolio
6.4.5 Mylan Pharmaceuticals Recent Developments/Updates
6.5 Arrow Pharma Pty Ltd
6.5.1 Arrow Pharma Pty Ltd Company Information
6.5.2 Arrow Pharma Pty Ltd Description and Business Overview
6.5.3 Arrow Pharma Pty Ltd Amiodarone Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Arrow Pharma Pty Ltd Amiodarone Product Portfolio
6.5.5 Arrow Pharma Pty Ltd Recent Developments/Updates
6.6 Roemmers
6.6.1 Roemmers Company Information
6.6.2 Roemmers Description and Business Overview
6.6.3 Roemmers Amiodarone Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Roemmers Amiodarone Product Portfolio
6.6.5 Roemmers Recent Developments/Updates
6.7 Cipla Pharmaceutical
6.7.1 Cipla Pharmaceutical Company Information
6.7.2 Cipla Pharmaceutical Description and Business Overview
6.7.3 Cipla Pharmaceutical Amiodarone Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Cipla Pharmaceutical Amiodarone Product Portfolio
6.7.5 Cipla Pharmaceutical Recent Developments/Updates
6.8 Shanghai Pharmaceuticals
6.8.1 Shanghai Pharmaceuticals Company Information
6.8.2 Shanghai Pharmaceuticals Description and Business Overview
6.8.3 Shanghai Pharmaceuticals Amiodarone Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Shanghai Pharmaceuticals Amiodarone Product Portfolio
6.8.5 Shanghai Pharmaceuticals Recent Developments/Updates
6.9 North China Pharmaceutical Company
6.9.1 North China Pharmaceutical Company Company Information
6.9.2 North China Pharmaceutical Company Description and Business Overview
6.9.3 North China Pharmaceutical Company Amiodarone Sales, Revenue and Gross Margin (2020-2025)
6.9.4 North China Pharmaceutical Company Amiodarone Product Portfolio
6.9.5 North China Pharmaceutical Company Recent Developments/Updates
6.10 Harbin Pharmaceutical Group
6.10.1 Harbin Pharmaceutical Group Company Information
6.10.2 Harbin Pharmaceutical Group Description and Business Overview
6.10.3 Harbin Pharmaceutical Group Amiodarone Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Harbin Pharmaceutical Group Amiodarone Product Portfolio
6.10.5 Harbin Pharmaceutical Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Amiodarone Industry Chain Analysis
7.2 Amiodarone Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Amiodarone Production Mode & Process Analysis
7.4 Amiodarone Sales and Marketing
7.4.1 Amiodarone Sales Channels
7.4.2 Amiodarone Distributors
7.5 Amiodarone Customer Analysis
8 Amiodarone Market Dynamics
8.1 Amiodarone Industry Trends
8.2 Amiodarone Market Drivers
8.3 Amiodarone Market Challenges
8.4 Amiodarone Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Amiodarone by Type
1.2.1 Global Amiodarone Market Value Comparison by Type (2024 VS 2031)
1.2.2 Tablet Amiodarone
1.2.3 Capsule Amiodarone
1.2.4 Injection Amiodarone
1.3 Amiodarone by Application
1.3.1 Global Amiodarone Market Value by Application (2024 VS 2031)
1.3.2 Cardiac Arrest
1.3.3 Ventricular Tachycardia
1.3.4 Atrial Fibrillation
1.3.5 Others
1.4 Global Amiodarone Market Size Estimates and Forecasts
1.4.1 Global Amiodarone Revenue 2020-2031
1.4.2 Global Amiodarone Sales 2020-2031
1.4.3 Global Amiodarone Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Amiodarone Market Competition by Manufacturers
2.1 Global Amiodarone Sales Market Share by Manufacturers (2020-2025)
2.2 Global Amiodarone Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Amiodarone Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Amiodarone, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Amiodarone, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Amiodarone, Product Type & Application
2.7 Global Key Manufacturers of Amiodarone, Date of Enter into This Industry
2.8 Global Amiodarone Market Competitive Situation and Trends
2.8.1 Global Amiodarone Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Amiodarone Players Market Share by Revenue
2.8.3 Global Amiodarone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Amiodarone Market Scenario by Region
3.1 Global Amiodarone Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Amiodarone Sales by Region: 2020-2031
3.2.1 Global Amiodarone Sales by Region: 2020-2025
3.2.2 Global Amiodarone Sales by Region: 2026-2031
3.3 Global Amiodarone Revenue by Region: 2020-2031
3.3.1 Global Amiodarone Revenue by Region: 2020-2025
3.3.2 Global Amiodarone Revenue by Region: 2026-2031
3.4 North America Amiodarone Market Facts & Figures by Country
3.4.1 North America Amiodarone Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Amiodarone Sales by Country (2020-2031)
3.4.3 North America Amiodarone Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Amiodarone Market Facts & Figures by Country
3.5.1 Europe Amiodarone Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Amiodarone Sales by Country (2020-2031)
3.5.3 Europe Amiodarone Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Amiodarone Market Facts & Figures by Region
3.6.1 Asia Pacific Amiodarone Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Amiodarone Sales by Region (2020-2031)
3.6.3 Asia Pacific Amiodarone Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Amiodarone Market Facts & Figures by Country
3.7.1 Latin America Amiodarone Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Amiodarone Sales by Country (2020-2031)
3.7.3 Latin America Amiodarone Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Amiodarone Market Facts & Figures by Country
3.8.1 Middle East and Africa Amiodarone Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Amiodarone Sales by Country (2020-2031)
3.8.3 Middle East and Africa Amiodarone Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Amiodarone Sales by Type (2020-2031)
4.1.1 Global Amiodarone Sales by Type (2020-2025)
4.1.2 Global Amiodarone Sales by Type (2026-2031)
4.1.3 Global Amiodarone Sales Market Share by Type (2020-2031)
4.2 Global Amiodarone Revenue by Type (2020-2031)
4.2.1 Global Amiodarone Revenue by Type (2020-2025)
4.2.2 Global Amiodarone Revenue by Type (2026-2031)
4.2.3 Global Amiodarone Revenue Market Share by Type (2020-2031)
4.3 Global Amiodarone Price by Type (2020-2031)
5 Segment by Application
5.1 Global Amiodarone Sales by Application (2020-2031)
5.1.1 Global Amiodarone Sales by Application (2020-2025)
5.1.2 Global Amiodarone Sales by Application (2026-2031)
5.1.3 Global Amiodarone Sales Market Share by Application (2020-2031)
5.2 Global Amiodarone Revenue by Application (2020-2031)
5.2.1 Global Amiodarone Revenue by Application (2020-2025)
5.2.2 Global Amiodarone Revenue by Application (2026-2031)
5.2.3 Global Amiodarone Revenue Market Share by Application (2020-2031)
5.3 Global Amiodarone Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Amiodarone Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Amiodarone Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Sawai Pharmaceutical
6.2.1 Sawai Pharmaceutical Company Information
6.2.2 Sawai Pharmaceutical Description and Business Overview
6.2.3 Sawai Pharmaceutical Amiodarone Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sawai Pharmaceutical Amiodarone Product Portfolio
6.2.5 Sawai Pharmaceutical Recent Developments/Updates
6.3 Wyeth Pharmaceuticals(Pfizer)
6.3.1 Wyeth Pharmaceuticals(Pfizer) Company Information
6.3.2 Wyeth Pharmaceuticals(Pfizer) Description and Business Overview
6.3.3 Wyeth Pharmaceuticals(Pfizer) Amiodarone Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Wyeth Pharmaceuticals(Pfizer) Amiodarone Product Portfolio
6.3.5 Wyeth Pharmaceuticals(Pfizer) Recent Developments/Updates
6.4 Mylan Pharmaceuticals
6.4.1 Mylan Pharmaceuticals Company Information
6.4.2 Mylan Pharmaceuticals Description and Business Overview
6.4.3 Mylan Pharmaceuticals Amiodarone Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Mylan Pharmaceuticals Amiodarone Product Portfolio
6.4.5 Mylan Pharmaceuticals Recent Developments/Updates
6.5 Arrow Pharma Pty Ltd
6.5.1 Arrow Pharma Pty Ltd Company Information
6.5.2 Arrow Pharma Pty Ltd Description and Business Overview
6.5.3 Arrow Pharma Pty Ltd Amiodarone Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Arrow Pharma Pty Ltd Amiodarone Product Portfolio
6.5.5 Arrow Pharma Pty Ltd Recent Developments/Updates
6.6 Roemmers
6.6.1 Roemmers Company Information
6.6.2 Roemmers Description and Business Overview
6.6.3 Roemmers Amiodarone Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Roemmers Amiodarone Product Portfolio
6.6.5 Roemmers Recent Developments/Updates
6.7 Cipla Pharmaceutical
6.7.1 Cipla Pharmaceutical Company Information
6.7.2 Cipla Pharmaceutical Description and Business Overview
6.7.3 Cipla Pharmaceutical Amiodarone Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Cipla Pharmaceutical Amiodarone Product Portfolio
6.7.5 Cipla Pharmaceutical Recent Developments/Updates
6.8 Shanghai Pharmaceuticals
6.8.1 Shanghai Pharmaceuticals Company Information
6.8.2 Shanghai Pharmaceuticals Description and Business Overview
6.8.3 Shanghai Pharmaceuticals Amiodarone Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Shanghai Pharmaceuticals Amiodarone Product Portfolio
6.8.5 Shanghai Pharmaceuticals Recent Developments/Updates
6.9 North China Pharmaceutical Company
6.9.1 North China Pharmaceutical Company Company Information
6.9.2 North China Pharmaceutical Company Description and Business Overview
6.9.3 North China Pharmaceutical Company Amiodarone Sales, Revenue and Gross Margin (2020-2025)
6.9.4 North China Pharmaceutical Company Amiodarone Product Portfolio
6.9.5 North China Pharmaceutical Company Recent Developments/Updates
6.10 Harbin Pharmaceutical Group
6.10.1 Harbin Pharmaceutical Group Company Information
6.10.2 Harbin Pharmaceutical Group Description and Business Overview
6.10.3 Harbin Pharmaceutical Group Amiodarone Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Harbin Pharmaceutical Group Amiodarone Product Portfolio
6.10.5 Harbin Pharmaceutical Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Amiodarone Industry Chain Analysis
7.2 Amiodarone Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Amiodarone Production Mode & Process Analysis
7.4 Amiodarone Sales and Marketing
7.4.1 Amiodarone Sales Channels
7.4.2 Amiodarone Distributors
7.5 Amiodarone Customer Analysis
8 Amiodarone Market Dynamics
8.1 Amiodarone Industry Trends
8.2 Amiodarone Market Drivers
8.3 Amiodarone Market Challenges
8.4 Amiodarone Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Amiodarone Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Amiodarone Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Amiodarone Market Competitive Situation by Manufacturers in 2024
Table 4. Global Amiodarone Sales (M Doses) of Key Manufacturers (2020-2025)
Table 5. Global Amiodarone Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Amiodarone Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Amiodarone Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Amiodarone Average Price (USD/K Doses) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Amiodarone, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Amiodarone, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Amiodarone, Product Type & Application
Table 12. Global Key Manufacturers of Amiodarone, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Amiodarone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amiodarone as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Amiodarone Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Amiodarone Sales by Region (2020-2025) & (M Doses)
Table 18. Global Amiodarone Sales Market Share by Region (2020-2025)
Table 19. Global Amiodarone Sales by Region (2026-2031) & (M Doses)
Table 20. Global Amiodarone Sales Market Share by Region (2026-2031)
Table 21. Global Amiodarone Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Amiodarone Revenue Market Share by Region (2020-2025)
Table 23. Global Amiodarone Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Amiodarone Revenue Market Share by Region (2026-2031)
Table 25. North America Amiodarone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Amiodarone Sales by Country (2020-2025) & (M Doses)
Table 27. North America Amiodarone Sales by Country (2026-2031) & (M Doses)
Table 28. North America Amiodarone Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Amiodarone Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Amiodarone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Amiodarone Sales by Country (2020-2025) & (M Doses)
Table 32. Europe Amiodarone Sales by Country (2026-2031) & (M Doses)
Table 33. Europe Amiodarone Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Amiodarone Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Amiodarone Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Amiodarone Sales by Region (2020-2025) & (M Doses)
Table 37. Asia Pacific Amiodarone Sales by Region (2026-2031) & (M Doses)
Table 38. Asia Pacific Amiodarone Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Amiodarone Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Amiodarone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Amiodarone Sales by Country (2020-2025) & (M Doses)
Table 42. Latin America Amiodarone Sales by Country (2026-2031) & (M Doses)
Table 43. Latin America Amiodarone Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Amiodarone Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Amiodarone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Amiodarone Sales by Country (2020-2025) & (M Doses)
Table 47. Middle East and Africa Amiodarone Sales by Country (2026-2031) & (M Doses)
Table 48. Middle East and Africa Amiodarone Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Amiodarone Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Amiodarone Sales (M Doses) by Type (2020-2025)
Table 51. Global Amiodarone Sales (M Doses) by Type (2026-2031)
Table 52. Global Amiodarone Sales Market Share by Type (2020-2025)
Table 53. Global Amiodarone Sales Market Share by Type (2026-2031)
Table 54. Global Amiodarone Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Amiodarone Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Amiodarone Revenue Market Share by Type (2020-2025)
Table 57. Global Amiodarone Revenue Market Share by Type (2026-2031)
Table 58. Global Amiodarone Price (USD/K Doses) by Type (2020-2025)
Table 59. Global Amiodarone Price (USD/K Doses) by Type (2026-2031)
Table 60. Global Amiodarone Sales (M Doses) by Application (2020-2025)
Table 61. Global Amiodarone Sales (M Doses) by Application (2026-2031)
Table 62. Global Amiodarone Sales Market Share by Application (2020-2025)
Table 63. Global Amiodarone Sales Market Share by Application (2026-2031)
Table 64. Global Amiodarone Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Amiodarone Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Amiodarone Revenue Market Share by Application (2020-2025)
Table 67. Global Amiodarone Revenue Market Share by Application (2026-2031)
Table 68. Global Amiodarone Price (USD/K Doses) by Application (2020-2025)
Table 69. Global Amiodarone Price (USD/K Doses) by Application (2026-2031)
Table 70. Sanofi Company Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Amiodarone Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 73. Sanofi Amiodarone Product
Table 74. Sanofi Recent Developments/Updates
Table 75. Sawai Pharmaceutical Company Information
Table 76. Sawai Pharmaceutical Description and Business Overview
Table 77. Sawai Pharmaceutical Amiodarone Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 78. Sawai Pharmaceutical Amiodarone Product
Table 79. Sawai Pharmaceutical Recent Developments/Updates
Table 80. Wyeth Pharmaceuticals(Pfizer) Company Information
Table 81. Wyeth Pharmaceuticals(Pfizer) Description and Business Overview
Table 82. Wyeth Pharmaceuticals(Pfizer) Amiodarone Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 83. Wyeth Pharmaceuticals(Pfizer) Amiodarone Product
Table 84. Wyeth Pharmaceuticals(Pfizer) Recent Developments/Updates
Table 85. Mylan Pharmaceuticals Company Information
Table 86. Mylan Pharmaceuticals Description and Business Overview
Table 87. Mylan Pharmaceuticals Amiodarone Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 88. Mylan Pharmaceuticals Amiodarone Product
Table 89. Mylan Pharmaceuticals Recent Developments/Updates
Table 90. Arrow Pharma Pty Ltd Company Information
Table 91. Arrow Pharma Pty Ltd Description and Business Overview
Table 92. Arrow Pharma Pty Ltd Amiodarone Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 93. Arrow Pharma Pty Ltd Amiodarone Product
Table 94. Arrow Pharma Pty Ltd Recent Developments/Updates
Table 95. Roemmers Company Information
Table 96. Roemmers Description and Business Overview
Table 97. Roemmers Amiodarone Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 98. Roemmers Amiodarone Product
Table 99. Roemmers Recent Developments/Updates
Table 100. Cipla Pharmaceutical Company Information
Table 101. Cipla Pharmaceutical Description and Business Overview
Table 102. Cipla Pharmaceutical Amiodarone Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 103. Cipla Pharmaceutical Amiodarone Product
Table 104. Cipla Pharmaceutical Recent Developments/Updates
Table 105. Shanghai Pharmaceuticals Company Information
Table 106. Shanghai Pharmaceuticals Description and Business Overview
Table 107. Shanghai Pharmaceuticals Amiodarone Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 108. Shanghai Pharmaceuticals Amiodarone Product
Table 109. Shanghai Pharmaceuticals Recent Developments/Updates
Table 110. North China Pharmaceutical Company Company Information
Table 111. North China Pharmaceutical Company Description and Business Overview
Table 112. North China Pharmaceutical Company Amiodarone Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 113. North China Pharmaceutical Company Amiodarone Product
Table 114. North China Pharmaceutical Company Recent Developments/Updates
Table 115. Harbin Pharmaceutical Group Company Information
Table 116. Harbin Pharmaceutical Group Description and Business Overview
Table 117. Harbin Pharmaceutical Group Amiodarone Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 118. Harbin Pharmaceutical Group Amiodarone Product
Table 119. Harbin Pharmaceutical Group Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Amiodarone Distributors List
Table 123. Amiodarone Customers List
Table 124. Amiodarone Market Trends
Table 125. Amiodarone Market Drivers
Table 126. Amiodarone Market Challenges
Table 127. Amiodarone Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Amiodarone
Figure 2. Global Amiodarone Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Amiodarone Market Share by Type: 2024 & 2031
Figure 4. Tablet Amiodarone Product Picture
Figure 5. Capsule Amiodarone Product Picture
Figure 6. Injection Amiodarone Product Picture
Figure 7. Global Amiodarone Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Amiodarone Market Share by Application: 2024 & 2031
Figure 9. Cardiac Arrest
Figure 10. Ventricular Tachycardia
Figure 11. Atrial Fibrillation
Figure 12. Others
Figure 13. Global Amiodarone Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Amiodarone Market Size (2020-2031) & (US$ Million)
Figure 15. Global Amiodarone Sales (2020-2031) & (M Doses)
Figure 16. Global Amiodarone Average Price (USD/K Doses) & (2020-2031)
Figure 17. Amiodarone Report Years Considered
Figure 18. Amiodarone Sales Share by Manufacturers in 2024
Figure 19. Global Amiodarone Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Amiodarone Players: Market Share by Revenue in Amiodarone in 2024
Figure 21. Amiodarone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Amiodarone Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Amiodarone Sales Market Share by Country (2020-2031)
Figure 24. North America Amiodarone Revenue Market Share by Country (2020-2031)
Figure 25. U.S. Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Amiodarone Sales Market Share by Country (2020-2031)
Figure 28. Europe Amiodarone Revenue Market Share by Country (2020-2031)
Figure 29. Germany Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Amiodarone Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Amiodarone Revenue Market Share by Region (2020-2031)
Figure 36. China Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Taiwan Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Philippines Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Latin America Amiodarone Sales Market Share by Country (2020-2031)
Figure 47. Latin America Amiodarone Revenue Market Share by Country (2020-2031)
Figure 48. Mexico Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Brazil Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Argentina Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Middle East and Africa Amiodarone Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Amiodarone Revenue Market Share by Country (2020-2031)
Figure 53. Turkey Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. U.A.E Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Global Sales Market Share of Amiodarone by Type (2020-2031)
Figure 57. Global Revenue Market Share of Amiodarone by Type (2020-2031)
Figure 58. Global Amiodarone Price (USD/K Doses) by Type (2020-2031)
Figure 59. Global Sales Market Share of Amiodarone by Application (2020-2031)
Figure 60. Global Revenue Market Share of Amiodarone by Application (2020-2031)
Figure 61. Global Amiodarone Price (USD/K Doses) by Application (2020-2031)
Figure 62. Amiodarone Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Global Amiodarone Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Amiodarone Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Amiodarone Market Competitive Situation by Manufacturers in 2024
Table 4. Global Amiodarone Sales (M Doses) of Key Manufacturers (2020-2025)
Table 5. Global Amiodarone Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Amiodarone Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Amiodarone Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Amiodarone Average Price (USD/K Doses) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Amiodarone, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Amiodarone, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Amiodarone, Product Type & Application
Table 12. Global Key Manufacturers of Amiodarone, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Amiodarone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amiodarone as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Amiodarone Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Amiodarone Sales by Region (2020-2025) & (M Doses)
Table 18. Global Amiodarone Sales Market Share by Region (2020-2025)
Table 19. Global Amiodarone Sales by Region (2026-2031) & (M Doses)
Table 20. Global Amiodarone Sales Market Share by Region (2026-2031)
Table 21. Global Amiodarone Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Amiodarone Revenue Market Share by Region (2020-2025)
Table 23. Global Amiodarone Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Amiodarone Revenue Market Share by Region (2026-2031)
Table 25. North America Amiodarone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Amiodarone Sales by Country (2020-2025) & (M Doses)
Table 27. North America Amiodarone Sales by Country (2026-2031) & (M Doses)
Table 28. North America Amiodarone Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Amiodarone Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Amiodarone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Amiodarone Sales by Country (2020-2025) & (M Doses)
Table 32. Europe Amiodarone Sales by Country (2026-2031) & (M Doses)
Table 33. Europe Amiodarone Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Amiodarone Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Amiodarone Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Amiodarone Sales by Region (2020-2025) & (M Doses)
Table 37. Asia Pacific Amiodarone Sales by Region (2026-2031) & (M Doses)
Table 38. Asia Pacific Amiodarone Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Amiodarone Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Amiodarone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Amiodarone Sales by Country (2020-2025) & (M Doses)
Table 42. Latin America Amiodarone Sales by Country (2026-2031) & (M Doses)
Table 43. Latin America Amiodarone Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Amiodarone Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Amiodarone Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Amiodarone Sales by Country (2020-2025) & (M Doses)
Table 47. Middle East and Africa Amiodarone Sales by Country (2026-2031) & (M Doses)
Table 48. Middle East and Africa Amiodarone Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Amiodarone Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Amiodarone Sales (M Doses) by Type (2020-2025)
Table 51. Global Amiodarone Sales (M Doses) by Type (2026-2031)
Table 52. Global Amiodarone Sales Market Share by Type (2020-2025)
Table 53. Global Amiodarone Sales Market Share by Type (2026-2031)
Table 54. Global Amiodarone Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Amiodarone Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Amiodarone Revenue Market Share by Type (2020-2025)
Table 57. Global Amiodarone Revenue Market Share by Type (2026-2031)
Table 58. Global Amiodarone Price (USD/K Doses) by Type (2020-2025)
Table 59. Global Amiodarone Price (USD/K Doses) by Type (2026-2031)
Table 60. Global Amiodarone Sales (M Doses) by Application (2020-2025)
Table 61. Global Amiodarone Sales (M Doses) by Application (2026-2031)
Table 62. Global Amiodarone Sales Market Share by Application (2020-2025)
Table 63. Global Amiodarone Sales Market Share by Application (2026-2031)
Table 64. Global Amiodarone Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Amiodarone Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Amiodarone Revenue Market Share by Application (2020-2025)
Table 67. Global Amiodarone Revenue Market Share by Application (2026-2031)
Table 68. Global Amiodarone Price (USD/K Doses) by Application (2020-2025)
Table 69. Global Amiodarone Price (USD/K Doses) by Application (2026-2031)
Table 70. Sanofi Company Information
Table 71. Sanofi Description and Business Overview
Table 72. Sanofi Amiodarone Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 73. Sanofi Amiodarone Product
Table 74. Sanofi Recent Developments/Updates
Table 75. Sawai Pharmaceutical Company Information
Table 76. Sawai Pharmaceutical Description and Business Overview
Table 77. Sawai Pharmaceutical Amiodarone Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 78. Sawai Pharmaceutical Amiodarone Product
Table 79. Sawai Pharmaceutical Recent Developments/Updates
Table 80. Wyeth Pharmaceuticals(Pfizer) Company Information
Table 81. Wyeth Pharmaceuticals(Pfizer) Description and Business Overview
Table 82. Wyeth Pharmaceuticals(Pfizer) Amiodarone Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 83. Wyeth Pharmaceuticals(Pfizer) Amiodarone Product
Table 84. Wyeth Pharmaceuticals(Pfizer) Recent Developments/Updates
Table 85. Mylan Pharmaceuticals Company Information
Table 86. Mylan Pharmaceuticals Description and Business Overview
Table 87. Mylan Pharmaceuticals Amiodarone Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 88. Mylan Pharmaceuticals Amiodarone Product
Table 89. Mylan Pharmaceuticals Recent Developments/Updates
Table 90. Arrow Pharma Pty Ltd Company Information
Table 91. Arrow Pharma Pty Ltd Description and Business Overview
Table 92. Arrow Pharma Pty Ltd Amiodarone Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 93. Arrow Pharma Pty Ltd Amiodarone Product
Table 94. Arrow Pharma Pty Ltd Recent Developments/Updates
Table 95. Roemmers Company Information
Table 96. Roemmers Description and Business Overview
Table 97. Roemmers Amiodarone Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 98. Roemmers Amiodarone Product
Table 99. Roemmers Recent Developments/Updates
Table 100. Cipla Pharmaceutical Company Information
Table 101. Cipla Pharmaceutical Description and Business Overview
Table 102. Cipla Pharmaceutical Amiodarone Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 103. Cipla Pharmaceutical Amiodarone Product
Table 104. Cipla Pharmaceutical Recent Developments/Updates
Table 105. Shanghai Pharmaceuticals Company Information
Table 106. Shanghai Pharmaceuticals Description and Business Overview
Table 107. Shanghai Pharmaceuticals Amiodarone Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 108. Shanghai Pharmaceuticals Amiodarone Product
Table 109. Shanghai Pharmaceuticals Recent Developments/Updates
Table 110. North China Pharmaceutical Company Company Information
Table 111. North China Pharmaceutical Company Description and Business Overview
Table 112. North China Pharmaceutical Company Amiodarone Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 113. North China Pharmaceutical Company Amiodarone Product
Table 114. North China Pharmaceutical Company Recent Developments/Updates
Table 115. Harbin Pharmaceutical Group Company Information
Table 116. Harbin Pharmaceutical Group Description and Business Overview
Table 117. Harbin Pharmaceutical Group Amiodarone Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2020-2025)
Table 118. Harbin Pharmaceutical Group Amiodarone Product
Table 119. Harbin Pharmaceutical Group Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Amiodarone Distributors List
Table 123. Amiodarone Customers List
Table 124. Amiodarone Market Trends
Table 125. Amiodarone Market Drivers
Table 126. Amiodarone Market Challenges
Table 127. Amiodarone Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Amiodarone
Figure 2. Global Amiodarone Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Amiodarone Market Share by Type: 2024 & 2031
Figure 4. Tablet Amiodarone Product Picture
Figure 5. Capsule Amiodarone Product Picture
Figure 6. Injection Amiodarone Product Picture
Figure 7. Global Amiodarone Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Amiodarone Market Share by Application: 2024 & 2031
Figure 9. Cardiac Arrest
Figure 10. Ventricular Tachycardia
Figure 11. Atrial Fibrillation
Figure 12. Others
Figure 13. Global Amiodarone Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Amiodarone Market Size (2020-2031) & (US$ Million)
Figure 15. Global Amiodarone Sales (2020-2031) & (M Doses)
Figure 16. Global Amiodarone Average Price (USD/K Doses) & (2020-2031)
Figure 17. Amiodarone Report Years Considered
Figure 18. Amiodarone Sales Share by Manufacturers in 2024
Figure 19. Global Amiodarone Revenue Share by Manufacturers in 2024
Figure 20. Global 5 and 10 Largest Amiodarone Players: Market Share by Revenue in Amiodarone in 2024
Figure 21. Amiodarone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Amiodarone Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. North America Amiodarone Sales Market Share by Country (2020-2031)
Figure 24. North America Amiodarone Revenue Market Share by Country (2020-2031)
Figure 25. U.S. Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Canada Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Europe Amiodarone Sales Market Share by Country (2020-2031)
Figure 28. Europe Amiodarone Revenue Market Share by Country (2020-2031)
Figure 29. Germany Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. France Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. U.K. Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Italy Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Russia Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Asia Pacific Amiodarone Sales Market Share by Region (2020-2031)
Figure 35. Asia Pacific Amiodarone Revenue Market Share by Region (2020-2031)
Figure 36. China Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Japan Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. South Korea Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. India Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Australia Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Taiwan Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Indonesia Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Thailand Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Malaysia Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Philippines Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Latin America Amiodarone Sales Market Share by Country (2020-2031)
Figure 47. Latin America Amiodarone Revenue Market Share by Country (2020-2031)
Figure 48. Mexico Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Brazil Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Argentina Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Middle East and Africa Amiodarone Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Amiodarone Revenue Market Share by Country (2020-2031)
Figure 53. Turkey Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. U.A.E Amiodarone Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Global Sales Market Share of Amiodarone by Type (2020-2031)
Figure 57. Global Revenue Market Share of Amiodarone by Type (2020-2031)
Figure 58. Global Amiodarone Price (USD/K Doses) by Type (2020-2031)
Figure 59. Global Sales Market Share of Amiodarone by Application (2020-2031)
Figure 60. Global Revenue Market Share of Amiodarone by Application (2020-2031)
Figure 61. Global Amiodarone Price (USD/K Doses) by Application (2020-2031)
Figure 62. Amiodarone Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Outdoor Shed Market Research Report 2025
Sep 09, 25
Global Residential Outdoor Cabinet Market Research Report 2025
Sep 09, 25
Global Outdoor Storage Cabinet Market Research Report 2025
Sep 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232